112th Meeting of the National Advisory Council on Drug Abuse

Neuroscience Center - Conference Rooms C & D
6001 Executive Boulevard, Bethesda, MD.

September 5, 2012

Closed Session

This meeting is closed to the public in accordance with the provisions set forth in section 552b{c} and 552b{c}(6), Title 5, U.S. Code and section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2).

2:00 p.m. Call to Order
Nora Volkow, M.D., Director, NIDA

Review of and Policy Procedures
Teresa Levitin, Ph.D., Executive Secretary,
National Advisory Council on Drug Abuse, NIDA
2:15 p.m. Council Review of Grant Applications
Nora Volkow, M.D., Director, NIDA

Division of Pharmacotherapies and Medical Consequences of Drug Abuse (DPMCDA)
Phil Skolnick, Ph.D., D.Sc. (hon.), Director
Division of Basic Neuroscience and Behavioral Research (DBNBR)
Joni Rutter, Ph.D., Acting Director

Division of Clinical Neuroscience and Behavioral Research (DCNBR)
Joseph Frascella, Ph.D., Director

Division of Epidemiology, Services, and Prevention Research (DESPR)
Wilson Compton, M.D., M.P.E., Director
4:00 p.m.  Adjourn

September 6, 2012

Open Session

8:30 a.m. Opening and Director's Report
Nora Volkow, M.D. Director, NIDA
9:30 a.m. Council Discussion
Council Members
10:00 a.m.
10:30 a.m. Medication Trials in Stimulant Dependence: An Update
David McCann, Ph.D.
Associate Director
Division of Pharmacotherapies and Medical Consequences of Drug Abuse (DPMCDA)
11:00 a.m. Adoption of NIDA's Evidence Based Treatments Workgroup Recommendations
Caryn Lerman, Ph.D.
Council Workgroup Chair and Mary W. Calkins Professor
University of Pennsylvania
11:45 a.m. Update on Loan Repayment Program
Susan Weiss, Ph.D.
Associate Director for Scientific Affairs, Office of the Director, NIDA
12:15 p.m. AIDS Program and International AIDS
Jacques Normand, Ph.D.
Director, AIDS Research Program (ARP) 
12:45 p.m. Public Comments
1:00 p.m. Adjourn


Page Tools

  • Share